Stephen K. Gruschkus

Author

The University of Texas MD Anderson Cancer Center

Also Known As

S K Gruschkus, S. Gruschkus, S. K. Gruschkus, Stephen Gruschkus, Stephen K Gruschkus, Stephen K. Gruschkus, Stephen Karl Gruschkus

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston Health Outcomes Solutions (United States)Eli Lilly (United States)Baylor College of Medicine

About

Stephen K. Gruschkus is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	66
2	Health Sciences	2	2	159
3	Management	1	1	134
4	Immunology	1	1	25
5	Pathology	1	1	11

Stephen K. Gruschkus

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Cost and Quality Implications of Opioid‐Based Postsurgical Pain Control Using Administrative Claims Data from a Large Health System: Opioid‐Related Adverse Events and Their Impact on Clinical and Economic Outcomes E. Richard Kessler, Manan Shah, Stephen K. Gruschkus, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2013	318
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study Meredith Pelster, Stephen K. Gruschkus, Roland L. Bassett, Journal of Clinical Oncology	2020	284
Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting Marcus A. Neubauer, J. Russell Hoverman, Michael Kolodziej, Journal of Oncology Practice	2010	172
Risk factors of myelodysplastic syndromes: a case–control study Sara S. Strom, Yiqun Gu, Stephen K. Gruschkus, Leukemia Hematological MalignancyRisk ManagementHematologyRiskManagement	2005	134
Influence of obesity on biochemical and clinical failure after external‐beam radiotherapy for localized prostate cancer Sara S. Strom, Ashish M. Kamat, Stephen K. Gruschkus, Cancer	2006	102
Adverse drug events among patients receiving postsurgical opioids in a large health system: Risk factors and outcomes Harold S. Minkowitz, Stephen K. Gruschkus, Manan Shah, American Journal of Health-System Pharmacy	2014	76
PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma Priyadharsini Nagarajan, Christian El‐Hadad, Stephen K. Gruschkus, Investigative Ophthalmology & Visual Science	2019	42
Development and Validation of a Risk Score to Identify Patients at High Risk for Opioid-Related Adverse Drug Events Harold S. Minkowitz, Richard E. Scranton, Stephen K. Gruschkus, Journal of Managed Care Pharmacy	2014	39
Bevacizumab Treatment to Progression After Chemotherapy: Outcomes from a U.S. Community Practice Network Eric Nadler, Elaine Yu, Arliene Ravelo, The Oncologist Residual PfsAdvanced NsclcOncologyBevacizumab MonotherapyBevacizumab Treatment	2011	30
Clinical Herpes Zoster in Antarctica as a Model for Spaceflight David Reyes, Alaina Brinley Rajagopal, Rebecca S. Blue, Aerospace Medicine and Human Performance	2017	28

Page 1